Article List

WPRIM Management System> DCMS> Journal of China Pharmaceutical University> 2023> 54> 2

1. Advances in immune checkpoint inhibitors combined with other treatments	Page:131—140
2. Development strategy and clinical research progress of universal chimeric antigen receptor T-cell drugs	Page:141—149
3. Advances in research on small intestinal injuries caused by nonsteroidal anti-inflammatory drugs and its prevention and treatment	Page:150—158
4. Research progress of boron-containing drugs	Page:159—171
5. Advances in research on mechanism of lactate dehydrogenase B in tumors	Page:172—179
6. Preparation of azithromycin-ion exchange resin complexes for taste-masking and controlled drug release	Page:180—187
7. Anti-senescence effect of acetyl dipeptide-1 cetyl ester on skin and its mechanism	Page:188—197
8. Metabolomics profiling of doxorubicin-induced cardiotoxicity in mice with lung injury	Page:198—207
9. Inhibition of total flavonoids from Abelmoschus Manihot on cytochrome P450	Page:208—217
10. Gut microbiota-mediated therapeutic effect of Shengmai formula (SMF) on sepsis in mice	Page:218—225
11. Bacteroides fragilis ATCC25285 relieves colitis by inducing Treg cells differentiation via the TGF-β/Smad3 signaling pathway	Page:226—237
12. Effects and mechanisms of SNP-9 on Parkinson''s disease cell model induced by rotenone	Page:238—244
13. Design and antitumor activity of programmed cell death ligand 1 epitope peptide vaccine	Page:245—254
14. Primer probes for targeted identification and detection of Bifidobacterium animalis and their application	Page:255—262